+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Throat Cancer Therapeutics Market 2024-2028

  • PDF Icon

    Report

  • 158 Pages
  • December 2023
  • Region: Global
  • TechNavio
  • ID: 5601858
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The throat cancer therapeutics market is forecasted to grow by USD 2.33 bn during 2023-2028, accelerating at a CAGR of 7.51% during the forecast period. The report on the throat cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of throat cancer, the growing use of tobacco products, and increasing risk factors for throat cancer.

The throat cancer therapeutics market is segmented as below:

By Type

  • Pharyngeal cancer
  • Laryngeal cancer

By Distribution Channel

  • Offline
  • Online

By Geography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the growing strategic alliances of the vendors as one of the prime reasons driving the throat cancer therapeutics market growth during the next few years. Also, rising adoption of patient assistance programs and strong pipeline of throat cancer therapeutics will lead to sizable demand in the market.

The report on the throat cancer therapeutics market covers the following areas:

  • Throat cancer therapeutics market sizing
  • Throat cancer therapeutics market forecast
  • Throat cancer therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading throat cancer therapeutics market vendors that include Adlai Nortye Ltd., Amgen Inc., AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Co., Celldex Therapeutics Inc., Clinigen Group Plc, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Merck KGaA, Moderna Inc, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., and Sanofi SA. Also, the throat cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global throat cancer therapeutics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global throat cancer therapeutics market 2018 - 2022 ($ billion)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.3 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Pharyngeal cancer - Market size and forecast 2023-2028
Exhibit 34: Chart on Pharyngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Pharyngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Pharyngeal cancer - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Pharyngeal cancer - Year-over-year growth 2023-2028 (%)
6.4 Laryngeal cancer - Market size and forecast 2023-2028
Exhibit 38: Chart on Laryngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Laryngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Laryngeal cancer - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Laryngeal cancer - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ billion)
Exhibit 43: Data Table on Market opportunity by Type ($ billion)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2023-2028
Exhibit 48: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibit 49: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Offline - Year-over-year growth 2023-2028 (%)
7.4 Online - Market size and forecast 2023-2028
Exhibit 52: Chart on Online - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Online - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 56: Market opportunity by Distribution Channel ($ billion)
Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share by geography 2023-2028 (%)
Exhibit 60: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 India - Market size and forecast 2023-2028
Exhibit 83: Chart on India - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on India - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on India - Year-over-year growth 2023-2028 (%)
9.9 Hungary - Market size and forecast 2023-2028
Exhibit 87: Chart on Hungary - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Hungary - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Hungary - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Hungary - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 Poland - Market size and forecast 2023-2028
Exhibit 95: Chart on Poland - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Poland - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Poland - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Poland - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 99: Market opportunity by geography ($ billion)
Exhibit 100: Data Tables on Market opportunity by geography ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Adlai Nortye Ltd.
Exhibit 107: Adlai Nortye Ltd. - Overview
Exhibit 108: Adlai Nortye Ltd. - Product / Service
Exhibit 109: Adlai Nortye Ltd. - Key offerings
12.4 Amgen Inc.
Exhibit 110: Amgen Inc. - Overview
Exhibit 111: Amgen Inc. - Product / Service
Exhibit 112: Amgen Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 113: AstraZeneca Plc - Overview
Exhibit 114: AstraZeneca Plc - Product / Service
Exhibit 115: AstraZeneca Plc - Key news
Exhibit 116: AstraZeneca Plc - Key offerings
12.6 Bayer AG
Exhibit 117: Bayer AG - Overview
Exhibit 118: Bayer AG - Business segments
Exhibit 119: Bayer AG - Key news
Exhibit 120: Bayer AG - Key offerings
Exhibit 121: Bayer AG - Segment focus
12.7 Bristol Myers Squibb Co.
Exhibit 122: Bristol Myers Squibb Co. - Overview
Exhibit 123: Bristol Myers Squibb Co. - Product / Service
Exhibit 124: Bristol Myers Squibb Co. - Key news
Exhibit 125: Bristol Myers Squibb Co. - Key offerings
12.8 Celldex Therapeutics Inc.
Exhibit 126: Celldex Therapeutics Inc. - Overview
Exhibit 127: Celldex Therapeutics Inc. - Product / Service
Exhibit 128: Celldex Therapeutics Inc. - Key offerings
12.9 Clinigen Group Plc
Exhibit 129: Clinigen Group Plc - Overview
Exhibit 130: Clinigen Group Plc - Product / Service
Exhibit 131: Clinigen Group Plc - Key offerings
12.10 Eli Lilly and Co.
Exhibit 132: Eli Lilly and Co. - Overview
Exhibit 133: Eli Lilly and Co. - Product / Service
Exhibit 134: Eli Lilly and Co. - Key news
Exhibit 135: Eli Lilly and Co. - Key offerings
12.11 F. Hoffmann La Roche Ltd.
Exhibit 136: F. Hoffmann La Roche Ltd. - Overview
Exhibit 137: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 138: F. Hoffmann La Roche Ltd. - Key news
Exhibit 139: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 140: F. Hoffmann La Roche Ltd. - Segment focus
12.12 Merck KGaA
Exhibit 141: Merck KGaA - Overview
Exhibit 142: Merck KGaA - Business segments
Exhibit 143: Merck KGaA - Key news
Exhibit 144: Merck KGaA - Key offerings
Exhibit 145: Merck KGaA - Segment focus
12.13 Moderna Inc
Exhibit 146: Moderna Inc - Overview
Exhibit 147: Moderna Inc - Product / Service
Exhibit 148: Moderna Inc - Key offerings
12.14 Novartis AG
Exhibit 149: Novartis AG - Overview
Exhibit 150: Novartis AG - Business segments
Exhibit 151: Novartis AG - Key offerings
Exhibit 152: Novartis AG - Segment focus
12.15 Pfizer Inc.
Exhibit 153: Pfizer Inc. - Overview
Exhibit 154: Pfizer Inc. - Product / Service
Exhibit 155: Pfizer Inc. - Key news
Exhibit 156: Pfizer Inc. - Key offerings
12.16 Regeneron Pharmaceuticals Inc.
Exhibit 157: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 158: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 159: Regeneron Pharmaceuticals Inc. - Key offerings
12.17 Sanofi SA
Exhibit 160: Sanofi SA - Overview
Exhibit 161: Sanofi SA - Business segments
Exhibit 162: Sanofi SA - Key news
Exhibit 163: Sanofi SA - Key offerings
Exhibit 164: Sanofi SA - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Type
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global throat cancer therapeutics market 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on Type - Market share 2023-2028 (%)
Exhibits 31: Data Table on Type - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by Type
Exhibits 33: Data Table on Comparison by Type
Exhibits 34: Chart on Pharyngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Pharyngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Pharyngeal cancer - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Pharyngeal cancer - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Laryngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on Laryngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on Laryngeal cancer - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Laryngeal cancer - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by Type ($ billion)
Exhibits 43: Data Table on Market opportunity by Type ($ billion)
Exhibits 44: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits 46: Chart on Comparison by Distribution Channel
Exhibits 47: Data Table on Comparison by Distribution Channel
Exhibits 48: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibits 49: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibits 50: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on Offline - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on Online - Market size and forecast 2023-2028 ($ billion)
Exhibits 53: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits 56: Market opportunity by Distribution Channel ($ billion)
Exhibits 57: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share by geography 2023-2028 (%)
Exhibits 60: Data Table on Market share by geography 2023-2028 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on India - Market size and forecast 2023-2028 ($ billion)
Exhibits 84: Data Table on India - Market size and forecast 2023-2028 ($ billion)
Exhibits 85: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Hungary - Market size and forecast 2023-2028 ($ billion)
Exhibits 88: Data Table on Hungary - Market size and forecast 2023-2028 ($ billion)
Exhibits 89: Chart on Hungary - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Hungary - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on Poland - Market size and forecast 2023-2028 ($ billion)
Exhibits 96: Data Table on Poland - Market size and forecast 2023-2028 ($ billion)
Exhibits 97: Chart on Poland - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on Poland - Year-over-year growth 2023-2028 (%)
Exhibits 99: Market opportunity by geography ($ billion)
Exhibits 100: Data Tables on Market opportunity by geography ($ billion)
Exhibits 101: Impact of drivers and challenges in 2023 and 2028
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: Adlai Nortye Ltd. - Overview
Exhibits 108: Adlai Nortye Ltd. - Product / Service
Exhibits 109: Adlai Nortye Ltd. - Key offerings
Exhibits 110: Amgen Inc. - Overview
Exhibits 111: Amgen Inc. - Product / Service
Exhibits 112: Amgen Inc. - Key offerings
Exhibits 113: AstraZeneca Plc - Overview
Exhibits 114: AstraZeneca Plc - Product / Service
Exhibits 115: AstraZeneca Plc - Key news
Exhibits 116: AstraZeneca Plc - Key offerings
Exhibits 117: Bayer AG - Overview
Exhibits 118: Bayer AG - Business segments
Exhibits 119: Bayer AG - Key news
Exhibits 120: Bayer AG - Key offerings
Exhibits 121: Bayer AG - Segment focus
Exhibits 122: Bristol Myers Squibb Co. - Overview
Exhibits 123: Bristol Myers Squibb Co. - Product / Service
Exhibits 124: Bristol Myers Squibb Co. - Key news
Exhibits 125: Bristol Myers Squibb Co. - Key offerings
Exhibits 126: Celldex Therapeutics Inc. - Overview
Exhibits 127: Celldex Therapeutics Inc. - Product / Service
Exhibits 128: Celldex Therapeutics Inc. - Key offerings
Exhibits 129: Clinigen Group Plc - Overview
Exhibits 130: Clinigen Group Plc - Product / Service
Exhibits 131: Clinigen Group Plc - Key offerings
Exhibits 132: Eli Lilly and Co. - Overview
Exhibits 133: Eli Lilly and Co. - Product / Service
Exhibits 134: Eli Lilly and Co. - Key news
Exhibits 135: Eli Lilly and Co. - Key offerings
Exhibits 136: F. Hoffmann La Roche Ltd. - Overview
Exhibits 137: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 138: F. Hoffmann La Roche Ltd. - Key news
Exhibits 139: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 140: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 141: Merck KGaA - Overview
Exhibits 142: Merck KGaA - Business segments
Exhibits 143: Merck KGaA - Key news
Exhibits 144: Merck KGaA - Key offerings
Exhibits 145: Merck KGaA - Segment focus
Exhibits 146: Moderna Inc - Overview
Exhibits 147: Moderna Inc - Product / Service
Exhibits 148: Moderna Inc - Key offerings
Exhibits 149: Novartis AG - Overview
Exhibits 150: Novartis AG - Business segments
Exhibits 151: Novartis AG - Key offerings
Exhibits 152: Novartis AG - Segment focus
Exhibits 153: Pfizer Inc. - Overview
Exhibits 154: Pfizer Inc. - Product / Service
Exhibits 155: Pfizer Inc. - Key news
Exhibits 156: Pfizer Inc. - Key offerings
Exhibits 157: Regeneron Pharmaceuticals Inc. - Overview
Exhibits 158: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits 159: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits 160: Sanofi SA - Overview
Exhibits 161: Sanofi SA - Business segments
Exhibits 162: Sanofi SA - Key news
Exhibits 163: Sanofi SA - Key offerings
Exhibits 164: Sanofi SA - Segment focus
Exhibits 165: Inclusions checklist
Exhibits 166: Exclusions checklist
Exhibits 167: Currency conversion rates for US$
Exhibits 168: Research methodology
Exhibits 169: Validation techniques employed for market sizing
Exhibits 170: Information sources
Exhibits 171: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global throat cancer therapeutics market: Adlai Nortye Ltd., Amgen Inc., AstraZeneca Plc, Bayer AG, Bristol Myers Squibb Co., Celldex Therapeutics Inc., Clinigen Group Plc, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Merck KGaA, Moderna Inc, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., and Sanofi SA.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is growing strategic alliances of the vendors.'

According to the report, one of the major drivers for this market is the increasing incidence of throat cancer.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Adlai Nortye Ltd.
  • Amgen Inc.
  • AstraZeneca Plc
  • Bayer AG
  • Bristol Myers Squibb Co.
  • Celldex Therapeutics Inc.
  • Clinigen Group Plc
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • Merck KGaA
  • Moderna Inc
  • Novartis AG
  • Pfizer Inc.
  • Regeneron Pharmaceuticals Inc.
  • Sanofi SA